SG11201407568YA - Method for undifferentiated growth of mesenchymal stem cell and method for concentration of mesenchymal stem cell - Google Patents

Method for undifferentiated growth of mesenchymal stem cell and method for concentration of mesenchymal stem cell

Info

Publication number
SG11201407568YA
SG11201407568YA SG11201407568YA SG11201407568YA SG11201407568YA SG 11201407568Y A SG11201407568Y A SG 11201407568YA SG 11201407568Y A SG11201407568Y A SG 11201407568YA SG 11201407568Y A SG11201407568Y A SG 11201407568YA SG 11201407568Y A SG11201407568Y A SG 11201407568YA
Authority
SG
Singapore
Prior art keywords
mesenchymal stem
stem cells
stem cell
flt
shh
Prior art date
Application number
SG11201407568YA
Other languages
English (en)
Inventor
Hiroyuki Abe
Hiroaki Kawasaki
Original Assignee
Hiroyuki Abe
Hiroaki Kawasaki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hiroyuki Abe, Hiroaki Kawasaki filed Critical Hiroyuki Abe
Publication of SG11201407568YA publication Critical patent/SG11201407568YA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/113—Acidic fibroblast growth factor (aFGF, FGF-1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2303—Interleukin-3 (IL-3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2306—Interleukin-6 (IL-6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
SG11201407568YA 2012-08-31 2013-08-08 Method for undifferentiated growth of mesenchymal stem cell and method for concentration of mesenchymal stem cell SG11201407568YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012192560A JP5856029B2 (ja) 2012-08-31 2012-08-31 間葉系幹細胞を未分化増殖させる方法、および間葉系幹細胞を濃縮する方法
PCT/JP2013/071559 WO2014034407A1 (ja) 2012-08-31 2013-08-08 間葉系幹細胞を未分化増殖させる方法、および間葉系幹細胞を濃縮する方法

Publications (1)

Publication Number Publication Date
SG11201407568YA true SG11201407568YA (en) 2015-01-29

Family

ID=50183223

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201407568YA SG11201407568YA (en) 2012-08-31 2013-08-08 Method for undifferentiated growth of mesenchymal stem cell and method for concentration of mesenchymal stem cell

Country Status (9)

Country Link
US (1) US9670461B2 (zh)
EP (1) EP2891713B1 (zh)
JP (1) JP5856029B2 (zh)
KR (1) KR101813269B1 (zh)
CN (1) CN104395460B (zh)
CA (1) CA2872852C (zh)
HK (1) HK1205187A1 (zh)
SG (1) SG11201407568YA (zh)
WO (1) WO2014034407A1 (zh)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2279474C (en) * 1998-07-31 2011-01-04 Stemcell Technologies Inc. Novel antibody composition for debulking blood and bone marrow samples from cml patients
AU2003207064B2 (en) * 2002-02-06 2006-07-13 Sanbio, Inc. Method of differentiating/inducing bone marrow interstitial cells into nerve cells and skeleton muscle cells by transferring Notch gene
AU2003278212B2 (en) * 2002-07-31 2009-07-09 Centre National De La Recherche Scientifique Stem cells derived from adipous tissue and differentiated cells derived from said cells
ES2265199B1 (es) * 2003-06-12 2008-02-01 Cellerix, S.L. Celulas madre adultas multipotentes procedentes de condrocitos desdiferenciados y sus aplicaciones.
EP1689377A4 (en) 2003-11-04 2008-10-22 Univ Maryland STEM CELL CULTURE MEDIUM AND METHOD FOR THE USE OF THIS MEDIUM AND CELLS
KR100823090B1 (ko) * 2004-11-22 2008-04-18 한훈 제대혈 유래 줄기세포를 이용한 척수하반신 마비의 세포치료용 조성물
WO2006128029A2 (en) * 2005-05-25 2006-11-30 University Of Virginia Patent Foundation Production of osteoclasts from adipose tissues
US20070128722A1 (en) * 2005-12-05 2007-06-07 Industrial Technology Research Institute Human mesenchymal stem cells and culturing methods thereof
US20080050347A1 (en) 2006-08-23 2008-02-28 Ichim Thomas E Stem cell therapy for cardiac valvular dysfunction
CA2676323A1 (en) 2007-01-18 2008-07-24 Suomen Punainen Risti, Veripalvelu Novel methods and reagents directed to production of cells
FI20075030A0 (fi) * 2007-01-18 2007-01-18 Suomen Punainen Risti Veripalv Menetelmä solujen modifioimiseksi
CA2679178A1 (en) * 2007-02-26 2008-09-04 Mount Sinai Hospital Compositions and methods for treating peripheral vascular diseases
WO2008137115A1 (en) * 2007-05-03 2008-11-13 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
US20100266558A1 (en) * 2007-12-18 2010-10-21 Dov Zipori Method and assay for glycosylation pattern detection related to cell state of stem cells
JP2009213448A (ja) * 2008-03-12 2009-09-24 Institute Of Physical & Chemical Research 間葉系細胞株の作成法とその利用
EP2356220A4 (en) * 2008-11-14 2012-07-18 Univ Louisville Res Found METHODS AND COMPOSITIONS FOR LONG-TERM HAEMATOPOIETIC REPAIR
EP2484689A4 (en) 2009-09-29 2013-05-15 Univ Kyushu Nat Univ Corp PEPTIDE-INHIBITING DIFFERENTIATION OF HEMATOPOETIC STEM CELLS OR HEMATOPOETIC PRE-CURING CELLS AND THEIR USE
CA2792802C (en) 2010-03-10 2017-10-31 Two Cells Co., Ltd. Cell preparation containing mesenchymal stem cells, and method for producing same
JP5704554B2 (ja) * 2010-04-14 2015-04-22 国立大学法人鳥取大学 ヒト幹細胞を肝細胞へと分化誘導する化合物
JP5888670B2 (ja) * 2010-11-18 2016-03-22 国立大学法人東京工業大学 骨芽細胞分化誘導用培養基材、骨芽細胞分化誘導方法、及び骨芽細胞製造方法

Also Published As

Publication number Publication date
CN104395460B (zh) 2019-06-18
KR20150022895A (ko) 2015-03-04
US9670461B2 (en) 2017-06-06
EP2891713A4 (en) 2016-01-27
HK1205187A1 (zh) 2015-12-11
KR101813269B1 (ko) 2017-12-29
US20140220686A1 (en) 2014-08-07
JP5856029B2 (ja) 2016-02-09
JP2014045733A (ja) 2014-03-17
CN104395460A (zh) 2015-03-04
CA2872852A1 (en) 2014-03-06
WO2014034407A1 (ja) 2014-03-06
EP2891713A1 (en) 2015-07-08
EP2891713B1 (en) 2018-11-07
CA2872852C (en) 2017-05-16

Similar Documents

Publication Publication Date Title
SG11201407917PA (en) Highly efficient method for establishing artificial pluripotent stem cell
SG11201806988UA (en) Improved differentiation method
SG11201909087PA (en) Perfusion medium
SG11201803169WA (en) Cellulase variants and polynucleotides encoding same
SG11201903407XA (en) Secretable variant immunomodulatory proteins and engineered cell therapy
SG11201408024TA (en) Method for obtaining monocytes or nk cells
SG11201407117TA (en) Composition for repairing cartilage tissue, method for producing same, and use thereof
SG11201810688UA (en) An electrically operated aerosol-generating system with a rechargeable power supply
SG11201811048UA (en) Single-cell transcript sequencing
SG11201907285XA (en) Methods and kits for generating mimetic innate immune cells from pluripotent stem cells
SG11201900772YA (en) Gene editing of car-t cells for the treatment of t cell malignancies with chimeric antigen receptors
SG11201407226WA (en) Improved methods of cell culture for adoptive cell therapy
SG11201900058YA (en) Method of generating mesenchymal stem cells and uses thereof
SG11201811250TA (en) Nicotine inhaler system
SG11201404276VA (en) METHOD FOR PRODUCING p-XYLENE AND/OR p-TOLUALDEHYDE
SG11201804510PA (en) Biparatopic polypeptides antagonizing wnt signaling in tumor cells
SG11201804997XA (en) Process for preparing non-cariogenic, sustained energy release juice
SG11201903329WA (en) Method for preparing electrocompetent yeast cells, and method for using said cells
SG11201407851RA (en) Synthesis of pyrrolo [2, 3 - b] pyridines
SG11201407551SA (en) Substrate and touch panel member using same
SG11201405137QA (en) ANTIGEN-BINDING MOLECULE FOR PROMOTING DISAPPEARANCE OF ANTIGEN VIA FcγRIIB
SG11201804888WA (en) Velocity model update with an inversion gradient
SG11201407592YA (en) Glass for magnetic recording medium substrate and usage thereof
SG11201407745RA (en) Package body
SG11201903428XA (en) Pluripotent stem cell assay